Association of HIV Status With Local Immune Response to Anal Squamous Cell Carcinoma
Elizabeth L. Yanik1, Genevieve J. Kaunitz2, Tricia R. Cottrell3, Farah Succaria2, Tracee L. McMiller4, Maria Libera Ascierto5, Jessica Esandrio2,6, Haiying Xu2, Aleksandra Ogurtsova2, Toby C. Cornish7,8, Evan J. Lipson5, Suzanne L. Topalian4, Eric A. Engels1, Janis M. Taube2,6
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland
2Department of Dermatology, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland
3Department of Pathology, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland
4Department of Surgery, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland
5Department of Oncology, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland
6Department of Dermatology, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland3Department of Pathology, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland
7Department of Pathology, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland6Department of Pathology, University of Colorado School of Medicine, Aurora
8Department of Pathology, University of Colorado School of Medicine, Aurora